Spontaneous regression of metastatic renal cell carcinoma following palliative irradiation of the primary tumour

This publication has 14 references indexed in Scilit:

• Regression of Metastatic Renal Cell Carcinoma After Cytoreductive Nephrectomy
  Journal of Urology, 1993
• Regression in Renal Cell Carcinoma as Re-expression of Cell Death in Kidney Development
  Perspectives in Biology and Medicine, 1992
• Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignancies
  The Lancet, 1990
• Continuous infusion recombinant interleukin-2 (rIL-2) in adoptive cellular therapy of renal carcinoma and other malignancies
  Cancer Treatment Reviews, 1989
• A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days
  Cancer Chemotherapy and Pharmacology, 1989
• Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies
  European Journal of Cancer and Clinical Oncology, 1989
• The role of medroxyprogesterone acetate (MPA) in the treatment of renal adenocarcinoma
  Cancer Treatment Reviews, 1988
• Tumor Necrosis Factor Not Detectable in Patients With Clinical Cancer Cachexia
  JNCI Journal of the National Cancer Institute, 1988
• Growth factors and cancer.
  1986
• Hormone-induced and spontaneous regression of metastatic renal cancer
  Cancer, 1973